NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OptiScan Biomedical Corporation

OptiScan Biomedical Corporation

Private
Hayward, CaliforniaHealthcare & Life Scienceshttps://dowdsgroup.com/

Last Round

Series E

Mar 20, 2019

Total Funding Raised

$56M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

OptiScan Biomedical Corporation is a medical device company that has developed an innovative monitoring platform for use in hospital intensive care units (ICUs) to support clinicians in detecting changes more rapidly in critically ill patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

bedside monitoring systemcontinuous glucose monitoringmetabolic monitoringICU monitoringpoint of care testingmid-infrared spectroscopyautomated blood samplingcritical carePOCTmulti-analyte monitoringmedical consumablesmedical devicerazor and blade modellactate monitoringScvO2 monitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OptiScan Biomedical Corporation Comps

Public and private peers based on sector, stage, and business model.

OptiScan Biomedical Corporation comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

OptiScan Biomedical Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series EMar 20, 2019
Series BOct 13, 2005

Key People

Founding team and executive leadership

Louise McClelland

Chief Executive Officer

Executive Team

OptiScan Biomedical Corporation Investors

Notable investors and investment history

OptiScan Biomedical Corporation investors
InvestorRounds
Prism Venture PartnersSeries B
MedVenture AssociatesSeries B
NGN CapitalSeries B
Morgenthaler VenturesSeries B
Sanders Morris HarrisSeries B
Ascension VenturesSeries B
Wellcome TrustSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2026

    Monthly visitors increased 451% MoM.

  • May 2, 2025

    Monthly visitors grew 179% MoM, reaching 1K.

OptiScan Biomedical Corporation Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OptiScan Biomedical Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OptiScan Biomedical Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersHayward, California
Employee Range175
Year FoundedN/A
Last FundingMar 20, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.